Although no studies have previously evaluated the efficacy and safety of combinational therapy using both VEGF-A and VEGFR-targeted agents for malignant gliomas, VEGFRs vaccination with Bev has the possibility of being applied in the treatment of malignant gliomas. This evidence concerns the gene VEGFA and malignant glioma.